Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» 4D Molecular Therapeutics
4D Molecular Therapeutics
4DMT Unveils More Positive Data for Wet AMD Candidate
BioSpace
Thu, 07/18/24 - 11:29 am
4D Molecular Therapeutics
wet age-related macular degeneration
4D-150
clinical trials
4DMT gene therapy cuts need for Eylea in wet AMD trial
Pharmaphorum
Mon, 02/5/24 - 10:09 am
4D Molecular Therapeutics
wet age-related macular degeneration
clinical trials
gene therapy
Eylea
4DMT provides clinical programme updates for its wet AMD gene therapy
Clinical Trials Arena
Tue, 07/18/23 - 11:40 am
4D Molecular Therapeutics
wet age-related macular degeneration
RNAi
4D-150
Astellas buys rights to 4D Molecular’s technology in latest gene therapy deal
BioPharma Dive
Mon, 07/10/23 - 09:34 pm
Astellas
4D Molecular Therapeutics
gene therapy
viral vectors
Spotlight – Cystic fibrosis developers take a deep breath
EP Vantage
Mon, 02/27/23 - 10:02 am
cystic fibrosis
MRNA
Vertex Pharmaceuticals
4D Molecular Therapeutics
Arcturus Therapeutics
Arrowhead Pharmaceuticals
Boehringer Ingelheim
Eloxx Pharmaceuticals
Krystal Biotech
Moderna Therapeutics
Oxford BioMedica
ReCode Therapeutics
SpliSense
Sumitomo Pharmaceuticals
Tessera Therapeutics
4DMT shoots for a $75M IPO, its second attempt to go public with its gene therapy vector programs
Endpoints
Wed, 11/18/20 - 12:12 pm
4D Molecular Therapeutics
IPOs
gene therapy
4DMT to Use $75 Million Series C to Advance Three Key Pipeline Products
BioSpace
Tue, 06/16/20 - 06:57 pm
4D Molecular Therapeutics
IPOs
gene therapy
Gene Therapy Focused 4D Molecular Therapeutics Files for $100 Million IPO
CP Wire
Tue, 10/1/19 - 11:07 am
4D Molecular Therapeutics
IPOs
gene therapy
Gene Therapy Focused 4D Molecular Therapeutics Files for $100 Million IPO
Tue, 10/1/19 - 09:30 am
4D Molecular Therapeutics
4 Companies Pfizer Just Increased Its Stake In
Yahoo/Benzinga
Mon, 01/11/16 - 11:59 am
Pfizer
BioAtla
NextCure
Cortexyme
4D Molecular Therapeutics